iTANK-technology platform
A universal CAR T-cell technology platform, compatible with any CAR T-cell therapy for a multi-targeted attack on solid tumors.
iTANK-platform"Göran lived with cancer for 25 years – then it disappeared in a month"
“For world-leading research in cancer immunotherapy. Through advanced molecular engineering, he has created innovative cell therapies that have progressed all the way from the laboratory to patients, with results that save lives.”
Elicera's strengths are based on a deep understanding of how cells and viruses can be genetically engineered to trigger a powerful immune response to cancer.
Di Yu, Head of Technical Operations and co-founder, tells more about Elicera in the film.
